LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Carmell (NASDAQ: CTCX)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CTCX Carmell
Bracken-Ferguson Kendra / officer: Chief Executive Officer
10/11/2024
Buy
$0.36
378,705
$136K
378,705
NASDAQ CTCX Carmell
Cassaday Bryan J. / officer: Chief Financial Officer
10/11/2024
Buy
$0.36
120,000
$43K
120,000
NASDAQ CTCX Carmell
Spenlehauer Gilles / director
10/11/2024
Buy
$0.36
76,878
$28K
76,878
NASDAQ CTCX Carmell
Sturgeon Patrick A / director
10/11/2024
Buy
$0.36
76,878
$28K
76,878
NASDAQ CTCX Carmell
Upton Richard A / director
10/11/2024
Buy
$0.36
76,878
$28K
76,878
NASDAQ CTCX Carmell
Gregory Kathryn / director
10/11/2024
Buy
$0.36
76,878
$28K
76,878
NASDAQ CTCX Carmell
Shukla Rajiv / director, 10 percent owner, officer: Chairman and CEO
10/11/2024
Buy
$0.36
876,878
$314K
876,878
NASDAQ CTCX Carmell
Frisch Scott M. / director
10/11/2024
Buy
$0.36
76,878
$28K
76,878

COPYRIGHT ©2023 HEALTH STOCKS HUB